Viveve Company

Viveve designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company offers Geneveve, a non-invasive solution that includes the Viveve System, a radio frequency generator; a reusable hand piece and single-use treatment tip; and other consumable accessories. The Geneveve is indicated for use in general procedures for electrocoagulation and hemostasis in the US. The firm markets its products through sales employees and distributors in Asia, Europe, the Middle East, Latin America, the United States, Canada, and internationally.

Last Funding Type: Post-IPO Equity
Funding Status: M&A
Headquarters: Englewood, Colorado, United States
Founded Date: 01-01-2005
Last Funding Date: 2018-02-12
Total Funding: $117,111,369
Employee Number: 51-100
Estimated Revenue: $1M to $10M
Investors Number: 6
Industry: Pelvic & Uterine Health Care